An often-silent liver condition that threatens the heart

Many Americans may have a potentially serious condition marked by a buildup of fat inside the liver. Known as metabolic dysfunction–associated steatotic liver disease (MASLD), it’s closely linked to a higher risk of cardiovascular disease. The root of the problem is usually excess weight—especially the accumulation of belly fat known as abdominal obesity. Weight gain can trigger a host of metabolic problems that cause blood sugar, blood pressure, and cholesterol levels to rise. All of these factors are closely linked to a higher risk of diabetes and cardiovascular disease. Heart disease is one of the common causes of death among people with MASLD.

Content restricted. Requires subscription

What you should know about recalls of cardiac devices

Implanted heart devices include pacemakers and implantable cardioverter defibrillators (ICDs), which monitor and correct abnormal heart rhythms. While very reliable, they are not perfect, and recalls of these devices affect thousands of people each year, according to a 2024 study. Testing the effectiveness and safety of cardiac devices is far more complicated than testing drugs. But efforts are under way to improve postmarket tracking of device complications by using electronic health records, Medicare databases, and registries developed in partnership with device manufacturers.

Content restricted. Requires subscription

When seizures strike

About three million American adults have epilepsy, which is marked by recurring seizures. But far more people will have a seizure that strikes for another reason. Seizure triggers include high fever, head injury, extreme lack of sleep, blood sugar fluctuations, alcohol or drug misuse, certain medications, brain infections, stroke, and eclampsia. People can help someone having a seizure by moving them away from hazards, preventing choking, and tracking details. Most seizures are not a medical emergency.

Content restricted. Requires subscription

Pap smears or self-swabs?

Pap tests, the mainstay screening method to detect cervical cancer, are uncomfortable for some women. In mid-2024, the FDA approved a new self-swab test that can detect human papillomavirus, which causes most cases of cervical cancer. The self-swab test collects cells from the vaginal wall instead of the cervix. Clinicians guide women on how to perform the test in a doctor’s office. The self-swab method offers women several benefits, including comfort, accuracy, and potentially greater access to screening.

Content restricted. Requires subscription